Via Wired, David Ewing Duncan writes for Portfolio.com about the direct-to-consumer personal genetics market, and how this has caught regulatory bodies and health care providers off guard. With the passage of GINA and an advisory committee at the Department of Health and Human Services advocating for tighter regulation of consumer genetic tests, the vetting has begun. "We welcome responsible regulation," says David Agus, co-founder of Navigenics. "There needs to be medical standards and a system for validating this information."